Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:CAPLIPOINTHealthcare
Clear all filters
NEWS
positive
Business Standard - Markets 31d ago

Caplin Point Lab jumps over 20% in five days

Caplin Point Laboratories surged 5.18% to Rs 2,374.45 on Tuesday, extending its winning streak to a fifth consecutive session.

CAPLIPOINTHealthcare
Caplin Point to attend TRINITY INDIA 2026 on May 28 - scanx.trade
neutral
Google News - India Markets 50d ago

Caplin Point to attend TRINITY INDIA 2026 on May 28 - scanx.trade

Caplin Point to attend TRINITY INDIA 2026 on May 28scanx.trade

CAPLIPOINTHealthcare
NEWS
positive
Business Standard - Markets 57d ago

Caplin Steriles receives USFDA approval for Foscarnet Sodium Injection

Caplin Steriles (CSL), a subsidiary company of Caplin Point Laboratories has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Foscarnet Sodium Injection (6000 mg/250 mL Infusion Bag), a generic therapeutic equivalent version of the Reference Listed Drug (RLD) Foscavir Injection from Clinigen Healthcare, (NDA 020068).

CAPLIPOINTHCGHCG-REHEALTHCARENIDANFinancial ServicesHealthcare
NEWS
positive
Business Standard - Markets 58d ago

Caplin Point Laboratories consolidated net profit rises 19.32% in the March 2026 quarter

Sales rise 19.45% to Rs 600.16 crore

CAPLIPOINTHealthcare
Caplin Point shares surge over 9% after Q4 results — Profit up 19%; dividend declared
positive
CNBC TV18 - Markets 58d ago

Caplin Point shares surge over 9% after Q4 results — Profit up 19%; dividend declared

Caplin Point’s board also approved an interim dividend of ₹4 per equity share for FY26. The company has fixed May 30, 2026, as the record date for determining shareholder eligibility for the dividend.

CAPLIPOINTDIVIDENDFinancial ServicesHealthcare
NEWS
positive
Business Standard - Markets 133d ago

Caplin receives USFDA approval for Desmopressin Acetate Injection

Caplin Steriles (Caplin), a Subsidiary Company of Caplin Point Laboratories, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Desmopressin Acetate Injection USP, 4 mcg/mL single-dose vials and 40 mcg/10 mL (4 mcg/mL) multiple-dose vials, a generic therapeutic equivalent version of the Reference Listed Drug (RLD) DDAVP (desmopressin acetate) Injection, 4 mcg/mL of Nordic Pharma Inc., (NDA 018938).

CAPLIPOINTHealthcare
Trade Spotlight: How should you trade Caplin Point, Max Health, Fortis Healthcare, Deepak Fertilisers, InterGlobe Aviation, and others on June 9?
neutral
Moneycontrol NaNd ago

Trade Spotlight: How should you trade Caplin Point, Max Health, Fortis Healthcare, Deepak Fertilisers, InterGlobe Aviation, and others on June 9?

Following the sharp sell-off, the market is expected to consolidate and trade in a range-bound manner. Below are some short-term trading ideas to consider.

CAPLIPOINTFORTISHCGHCG-REHEALTHCAREINDIGOMAXHEALTHMAXINDMEDANTAFinancial ServicesHealthcare